Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

Similar articles for PubMed (Select 21273608)

1.

Expression of LGR5, an intestinal stem cell marker, during each stage of colorectal tumorigenesis.

Takeda K, Kinoshita I, Shimizu Y, Matsuno Y, Shichinohe T, Dosaka-Akita H.

Anticancer Res. 2011 Jan;31(1):263-70.

PMID:
21273608
2.

In situ validation of an intestinal stem cell signature in colorectal cancer.

Ziskin JL, Dunlap D, Yaylaoglu M, Fodor IK, Forrest WF, Patel R, Ge N, Hutchins GG, Pine JK, Quirke P, Koeppen H, Jubb AM.

Gut. 2013 Jul;62(7):1012-23. doi: 10.1136/gutjnl-2011-301195. Epub 2012 May 25.

PMID:
22637696
3.

OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells.

van der Flier LG, Haegebarth A, Stange DE, van de Wetering M, Clevers H.

Gastroenterology. 2009 Jul;137(1):15-7. doi: 10.1053/j.gastro.2009.05.035. Epub 2009 May 18. No abstract available.

PMID:
19450592
4.

CD133 mRNA expression and microsatellite instability in colorectal carcinoma.

Huh JW, Park YS, Lee JH, Kim HR, Shin MG, Kim YJ.

J Surg Oncol. 2010 Dec 1;102(7):765-70. doi: 10.1002/jso.21734.

PMID:
20872808
5.

MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma.

Atkins D, Breuckmann A, Schmahl GE, Binner P, Ferrone S, Krummenauer F, Störkel S, Seliger B.

Int J Cancer. 2004 Mar 20;109(2):265-73.

PMID:
14750179
6.

Expression of Lgr5 in human colorectal carcinogenesis and its potential correlation with beta-catenin.

Fan XS, Wu HY, Yu HP, Zhou Q, Zhang YF, Huang Q.

Int J Colorectal Dis. 2010 May;25(5):583-90. doi: 10.1007/s00384-010-0903-z. Epub 2010 Feb 27.

PMID:
20195621
7.

The Immunohistochemical expression of endothelial cell differentiation gene-2 receptor in human colorectal adenomas.

Komuro Y, Watanabe T, Kitayama J, Yamaguchi H, Tsuno N, Nagawa H.

Hepatogastroenterology. 2003 Nov-Dec;50(54):1770-3.

PMID:
14696401
8.

LGR5 promotes survival in human colorectal adenoma cells and is upregulated by PGE2: implications for targeting adenoma stem cells with NSAIDs.

Al-Kharusi MR, Smartt HJ, Greenhough A, Collard TJ, Emery ED, Williams AC, Paraskeva C.

Carcinogenesis. 2013 May;34(5):1150-7. doi: 10.1093/carcin/bgt020. Epub 2013 Jan 24.

9.

Significance of Lgr5(+ve) cancer stem cells in the colon and rectum.

Takahashi H, Ishii H, Nishida N, Takemasa I, Mizushima T, Ikeda M, Yokobori T, Mimori K, Yamamoto H, Sekimoto M, Doki Y, Mori M.

Ann Surg Oncol. 2011 Apr;18(4):1166-74. doi: 10.1245/s10434-010-1373-9. Epub 2010 Dec 2.

PMID:
21125339
10.

Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 in colorectal cancer.

Uchida H, Yamazaki K, Fukuma M, Yamada T, Hayashida T, Hasegawa H, Kitajima M, Kitagawa Y, Sakamoto M.

Cancer Sci. 2010 Jul;101(7):1731-7. doi: 10.1111/j.1349-7006.2010.01571.x. Epub 2010 Mar 24. Erratum in: Cancer Sci. 2010 Jul;101(7):1767.

PMID:
20384634
11.

Immunostaining of Lgr5, an intestinal stem cell marker, in normal and premalignant human gastrointestinal tissue.

Becker L, Huang Q, Mashimo H.

ScientificWorldJournal. 2008 Nov 23;8:1168-76. doi: 10.1100/tsw.2008.148.

12.

Expression of the adult intestinal stem cell marker Lgr5 in the metastatic cascade of colorectal cancer.

Kleist B, Xu L, Li G, Kersten C.

Int J Clin Exp Pathol. 2011 Apr;4(4):327-35. Epub 2011 Apr 25.

13.

Lgr5 is a potential marker of colorectal carcinoma stem cells that correlates with patient survival.

Wu XS, Xi HQ, Chen L.

World J Surg Oncol. 2012 Nov 15;10:244. doi: 10.1186/1477-7819-10-244.

14.

Significance of p-STAT3 expression in human colorectal adenocarcinoma.

Park JK, Hong R, Kim KJ, Lee TB, Lim SC.

Oncol Rep. 2008 Sep;20(3):597-604.

PMID:
18695911
15.

Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer.

Shida D, Watanabe T, Aoki J, Hama K, Kitayama J, Sonoda H, Kishi Y, Yamaguchi H, Sasaki S, Sako A, Konishi T, Arai H, Nagawa H.

Lab Invest. 2004 Oct;84(10):1352-62.

16.

Lgr5, an intestinal stem cell marker, is abnormally expressed in Barrett's esophagus and esophageal adenocarcinoma.

Becker L, Huang Q, Mashimo H.

Dis Esophagus. 2010 Feb;23(2):168-74. doi: 10.1111/j.1442-2050.2009.00979.x. Epub 2009 Jun 22.

PMID:
19549212
17.

Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival.

Yoo PS, Sullivan CA, Kiang S, Gao W, Uchio EM, Chung GG, Cha CH.

Ann Surg Oncol. 2009 Jan;16(1):200-7. doi: 10.1245/s10434-008-0209-3. Epub 2008 Nov 14.

PMID:
19009247
18.

Age-related alteration in the association of microsatellite instability with absent hMLH1 expression and histological types of colorectal carcinoma.

Arai T, Sugai T, Kasahara I, Sawabe M, Honma N, Aida J, Nakamura S, Takubo K.

Pathol Int. 2006 Oct;56(10):597-603.

PMID:
16984616
19.

[Expression and significance of Bmi-1 and Ki67 in colorectal carcinoma tissues].

Lin MX, Wen ZF, Feng ZY, He D.

Ai Zheng. 2008 Dec;27(12):1321-6. Chinese.

PMID:
19080002
20.

Elevated expression of A3 adenosine receptors in human colorectal cancer is reflected in peripheral blood cells.

Gessi S, Cattabriga E, Avitabile A, Gafa' R, Lanza G, Cavazzini L, Bianchi N, Gambari R, Feo C, Liboni A, Gullini S, Leung E, Mac-Lennan S, Borea PA.

Clin Cancer Res. 2004 Sep 1;10(17):5895-901.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk